Tetrachlorodecaoxide

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Tetrachlorodecaoxide
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ECHA InfoCard100.101.959 Edit this at Wikidata
  (verify)

Tetrachlorodecaoxide (TCDO) is a chlorite-containing, immunomodulatory, macrophage-activating drug whose chemical formula is Cl4H2O11.[1][2][3][4] The drug WF10 (Macrokine, Immunokine) is an aqueous solution of tetrachlorodecaoxide designed for intravenous injection.[3] Tetrachlorodecaoxide and WF10 were originally developed by Oxo Chemie.[5]

Tetrachlorodecaoxide / WF10 is used in the management of radiation cystitis,[6] is effective in the treatment of diabetic foot ulcers,[7] and is used in wound healing, where the mechanism of action is activation of the macrophage system, and increasing the partial pressure of oxygen in the wound.[8]

References[edit]

  1. ^ "Tetrachlorodecaoxide - Cl4H2O11-4". Pubchem.ncbi.nlm.mih.gov. Retrieved 2016-12-20.
  2. ^ "92047-76-2, molecular oxygen tetrachlorite hydrate, CAS No 92047-76-2 molecular oxygen tetrachlorite hydrate". Chemnet.com. Retrieved 2016-12-20.
  3. ^ a b "WF10". Drugprofiles.informa.com. Retrieved 2016-12-20.
  4. ^ Maraprygsavan, Paiboon; Mongkolsuk, Jarasporn; Arnhold, Juergen; Kuehne, Friedrich-Wilhelm (2016). "The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome". Journal of Clinical & Translational Endocrinology. 4: 53–8. doi:10.1016/j.jcte.2016.05.001.
  5. ^ "About Us - Immunokine® - WF10 - OXO Chemie (Thailand) Co., Ltd". Oxothai.com. Retrieved 2016-12-20.
  6. ^ Smit, Shaun G.; Heyns, Chris F. (2010). "Management of radiation cystitis". Nature Reviews Urology. 7 (4): 206–14. doi:10.1038/nrurol.2010.23. PMID 20212517.
  7. ^ Yingsakmongkol, N. (2013). "Clinical outcomes of WF10 adjunct to standard treatment of diabetic foot ulcers". Journal of Wound Care. 22 (3): 130–2, 134–6. doi:10.12968/jowc.2013.22.3.130. PMID 23665731.
  8. ^ Parikh, Romil; Bakhshi, Girish; Naik, Madhushree; Gaikwad, Bhargav; Jadhav, Kavita; Tayade, Mukund (2016). "The Efficacy and Safety of Tetrachlorodecaoxide in Comparison with Super-oxidised Solution in Wound Healing". Archives of Plastic Surgery. 43 (5): 395–401. doi:10.5999/aps.2016.43.5.395. PMC 5040840. PMID 27689045.

External links[edit]